54
Views
64
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study

, , , , , , , & show all
Pages 1691-1701 | Accepted 03 Sep 2004, Published online: 21 Sep 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Genovefa D. Kolovou, Vana Kolovou & Sophie Mavrogeni. (2016) Cigarette smoking/cessation and metabolic syndrome. Clinical Lipidology 11:1, pages 6-14.
Read now
Guan-Qi Fan, Kai-Li Fu, Ming Song, Lu Han, Cheng-Wei Jin, Ming Zhong, Yun Zhang, Wei Zhang & Zhi-Hao Wang. (2015) The impact of metabolic syndrome and hypertension on medical costs of patients with acute myocardial infarction at hospital. Clinical and Experimental Hypertension 37:8, pages 627-632.
Read now
Vasilios G. Athyros, Emmanuel S. Ganotakis, Konstantinos Tziomalos, Athanasios A. Papageorgiou, Panagiotis Anagnostis, Theodora Griva, Konstantinos Kargiotis, Eydoxia K. Mitsiou, Asterios Karagiannis & Dimitri P. Mikhailidis. (2010) Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Current Medical Research and Opinion 26:3, pages 713-719.
Read now
V. G. Athyros, A. Hatzitolios, A. Karagiannis, T. P. Didangelos, F. Iliadis, S. Dolgyras, T. Vosnakidis, P. Vasiliadis, I. Malias, K. Tziomalos, M. Samouilidou & D. P. Mikhailidis. (2009) Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study. Current Medical Research and Opinion 25:8, pages 1931-1940.
Read now
Haralampos J. Milionis, Moses S. Elisaf & Dimitri P. Mikhailidis. (2008) Lipid abnormalities and cardiovascular risk in the elderly. Current Medical Research and Opinion 24:3, pages 653-657.
Read now
Nicolas W Shammas. (2007) Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vascular Health and Risk Management 3:2, pages 229-234.
Read now
Vasilios G Athyros, Konstantinos Tziomalos, Dimitri P Mikhailidis, Efstathios D Pagourelias, Anna I Kakafika, Athanasios Skaperdas, Apostolos Hatzitolios & Asterios Karagiannis. (2007) Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opinion on Pharmacotherapy 8:14, pages 2267-2277.
Read now
Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, Anna I Kakafika, Konstantinos Tziomalos, Evangelos N Liberopoulos, Matilda Florentin & Moses Elisaf. (2007) The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opinion on Therapeutic Targets 11:2, pages 191-205.
Read now
Irene F Gazi, Vasilis Tsimihodimos, Alexandros D Tselepis, Moses Elisaf & Dimitri P Mikhailidis. (2007) Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opinion on Biological Therapy 7:1, pages 53-72.
Read now
Konstantinos Tziomalos & Vasilios G Athyros. (2006) Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review. International Journal of Nanomedicine 1:2, pages 129-147.
Read now
Irene F Gazi & Dimitri P Mikhailidis. (2006) Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview. Expert Opinion on Therapeutic Targets 10:6, pages 851-866.
Read now
Albert Császár, Ede Kékes, Tánja Abel, Renata Papp, István Kiss & Sándor Balogh. (2006) Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Pressure 15:2, pages 101-106.
Read now
T. D. Filippatos, D. N. Kiortsis, E. N. Liberopoulos, M. Georgoula, D. P. Mikhailidis & M. S. Elisaf. (2005) Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. Current Medical Research and Opinion 21:12, pages 1997-2006.
Read now

Articles from other publishers (51)

Michael J. GimbelIIIIII. 2022. Peripheral Arterial Interventions. Peripheral Arterial Interventions 49 59 .
Pishoy Gouda, Chinthanie Ramasundarahettige, Sonia Anand, Eva Muhlhoffer, Scott Berkowitz, Keith AA. Fox, John Eikelboom & Robert Welsh. (2021) Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial. Atherosclerosis 331, pages 38-44.
Crossref
T. A. Mulerova, D. P. Tsygankova & M. Yu. Ogarkov. (2021) Polymorphic variants of ACE, AGT, AGTR1, MTHFR and NOS3 candidate genes connected with arterial hypertension as part of the metabolic syndrome among the shor people. Obesity and metabolism 18:2, pages 190-197.
Crossref
A. Kokkinopoulou & A. Kafatos. (2021) Impact of Christian Orthodox Church dietary recommendations on metabolic syndrome risk factors: a scoping review. Nutrition Research Reviews, pages 1-15.
Crossref
Megan E. Holmes. 2018. Handbuch Stressregulation und Sport. Handbuch Stressregulation und Sport 311 323 .
A. D. Farcaș, M. A. Stoia, F. A. Anton, A. I. Roman & L. A. Vida-Simiti. 2017. International Conference on Advancements of Medicine and Health Care through Technology; 12th - 15th October 2016, Cluj-Napoca, Romania. International Conference on Advancements of Medicine and Health Care through Technology; 12th - 15th October 2016, Cluj-Napoca, Romania 57 60 .
Ivana Božić-Antić, Dušan Ilić, Jelica Bjekić-Macut, Tamara Bogavac, Danijela Vojnović-Milutinović, Biljana Kastratovic-Kotlica, Nataša Milić, Olivera Stanojlović, Zoran Andrić & Djuro Macut. (2016) Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome. European Journal of Endocrinology 175:6, pages 551-560.
Crossref
Rosa-M Valls, Elisabet Llauradó, Sara Fernández-Castillejo, Francesc Puiggrós, Rosa Solà, Lluis Arola & Anna Pedret. (2016) Effects of low molecular weight procyanidin rich extract from french maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-blind, crossover, placebo-controlled intervention trial. Phytomedicine 23:12, pages 1451-1461.
Crossref
Megan E. Holmes. 2017. Handbuch Stressregulation und Sport. Handbuch Stressregulation und Sport 1 17 .
Nicolas W. Shammas. 2015. Lasers in Cardiovascular Interventions. Lasers in Cardiovascular Interventions 157 166 .
Alexia L. Katsarou, Filippos Triposkiadis & Demosthenes Panagiotakos. (2012) Perceived Stress and Vascular Disease. Angiology 64:7, pages 529-534.
Crossref
Genovefa Kolovou & Teik Chye Ooi. (2013) Postprandial lipaemia and vascular disease. Current Opinion in Cardiology 28:4, pages 446-451.
Crossref
Michael S. Kostapanos, Moses S. Elisaf & Dimitri P. Mikhailidis. (2012) Obstructive Sleep Apnea and Cardiovascular Risk. Angiology 63:8, pages 569-573.
Crossref
N. Rao, S. V. Eastwood, A. Jain, M. Shah, B. Leurent, D. Harvey, L. Robertson, K. Walters, J. W. Persaud, D. P. Mikhailidis & D. R. Nair. (2012) Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. International Journal of Clinical Practice 66:3, pages 262-269.
Crossref
Nora L. Nock. 2012. Energy Balance and Gastrointestinal Cancer. Energy Balance and Gastrointestinal Cancer 1 22 .
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas & George Chrousos. (2011) Metabolic syndrome: definitions and controversies. BMC Medicine 9:1.
Crossref
Nikos Maniadakis, Georgia Kourlaba & Vasileios Fragoulakis. (2011) Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; A telephone survey. BMC Cardiovascular Disorders 11:1.
Crossref
Niki Katsiki, Vasilios G. Athyros & Dimitri P. Mikhailidis. (2011) Does Metabolic Syndrome Influence Outcome Following Percutaneous Coronary Intervention?. Angiology 62:6, pages 437-439.
Crossref
Judith L. Meadows & Douglas E. Vaughan. (2011) Endothelial biology in the post-menopausal obese woman. Maturitas 69:2, pages 120-125.
Crossref
Nikos Maniadakis, Mattias Ekman, Vasilios Fragoulakis, Vasiliki Papagiannopoulou & John Yfantopoulos. (2010) Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece. The European Journal of Health Economics 12:3, pages 253-261.
Crossref
George Ntaios, Christos Savopoulos, Stavros Chatzopoulos, Dimitri Mikhailidis & Apostolos Hatzitolios. (2011) Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: A systematic review and metaanalysis. Atherosclerosis 214:1, pages 11-19.
Crossref
Theodosios D Filippatos. (2010) Combination drug treatment in obese diabetic patients. World Journal of Diabetes 1:1, pages 8.
Crossref
Panagiotis Anagnostis, Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P. Mikhailidis. (2009) The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis. The Journal of Clinical Endocrinology & Metabolism 94:8, pages 2692-2701.
Crossref
Apostolos I. Hatzitolios, Triandafillos P. Didangelos, Anestis T. Zantidis, Konstantinos Tziomalos, George A. Giannakoulas & Dimitrios T. Karamitsos. (2009) Diabetes mellitus and cerebrovascular disease: which are the actual data?. Journal of Diabetes and its Complications 23:4, pages 283-296.
Crossref
Asterios Karagiannis, Apostolos I Hatzitolios, Vasilios G Athyros, Kalliopi Deligianni, Charalambos Charalambous, Christos Papathanakis, Georgios Theodosiou, Theodoros Drakidis, Veronika Chatzikaloudi, Chysanthi Kamilali, Sotirios Matsiras, Athanasios Matziris, Christos Savopoulos, Maria Baltatzi, Jobst Rudolf, Konstantinos Tziomalos & Dimitri P Mikhailidis. (2009) Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study. The Open Cardiovascular Medicine Journal 3:1, pages 26-34.
Crossref
José Ramón González-Juanatey, Eduardo Alegría Ezquerra, Ramón Gomis Barberá, María Jesús Salvador Taboada, Lilian Grigorian Shamagian, José Antonio Casasnovas Lenguas, Víctor López García-Aranda, Domingo Acosta Delgado, Javier Salvador Rodríguez, Antonio Hernández Mijares & Arantxa Matalí Gilarranz. (2009) Disfunción eréctil como marcador de vasculopatía en la diabetes mellitus tipo 2 en España. Estudio DIVA. Medicina Clínica 132:8, pages 291-297.
Crossref
Vasilios G. Athyros, Anna I. Kakafika, Asterios Karagiannis & Dimitri P. Mikhailidis. (2008) Do we need to consider inflammatory markers when we treat atherosclerotic disease?. Atherosclerosis 200:1, pages 1-12.
Crossref
Irene Bargellini, Pasquale Petruzzi, Alessia Scatena, Roberto Cioni, Antonio Cicorelli, Claudio Vignali, Loredana Rizzo, Alberto Piaggesi & Carlo Bartolozzi. (2008) Primary Infrainguinal Subintimal Angioplasty in Diabetic Patients. CardioVascular and Interventional Radiology 31:4, pages 713-722.
Crossref
Michael J. Blaha, Tebeb Gebretsadik, Ayumi Shintani & Tom A. Elasy. (2012) Waist Circumference, Not the Metabolic Syndrome, Predicts Glucose Deterioration in Type 2 Diabetes. Obesity 16:4, pages 869-874.
Crossref
Davide Noto, Carlo Maria Barbagallo, Angelo Baldassare Cefalù, Angelo Falletta, Michelangelo Sapienza, Giovanni Cavera, Salvatore Amato, Michele Pagano, Maria Maggiore, Antonio Carroccio, Alberto Notarbartolo & Maurizio R. Averna. (2008) The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 197:1, pages 147-153.
Crossref
T. D. Filippatos, C. S. Derdemezis, I. F. Gazi, K. Lagos, D. N. Kiortsis, A. D. Tselepis & M. S. Elisaf. (2007) Increased plasma visfatin levels in subjects with the metabolic syndrome. European Journal of Clinical Investigation 38:1, pages 71-72.
Crossref
Vasilios G. Athyros, Evangelos N. Liberopoulos, Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, Emmanuel S. Ganotakis, Konstantinos Tziomalos, Anna I. Kakafika, Asterios Karagiannis, Stylianos Lambropoulos & Moses Elisaf. (2007) Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort. Angiology 58:6, pages 689-697.
Crossref
T.D. Filippatos, I.F. Gazi, E.N. Liberopoulos, V.G. Athyros, M.S. Elisaf, A.D. Tselepis & D.N. Kiortsis. (2007) The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome. Atherosclerosis 193:2, pages 428-437.
Crossref
H. J. Milionis, T. D. Filippatos, C. S. Derdemezis, K. J. Kalantzi, J. Goudevenos, K. Seferiadis, D. P. Mikhailidis & M. S. Elisaf. (2007) Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. European Journal of Neurology 14:7, pages 762-769.
Crossref
Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Klelia D. Salpea & Dimitri P. Mikhailidis. (2007) The Prevalence of Metabolic Syndrome in Various Populations. The American Journal of the Medical Sciences 333:6, pages 362-371.
Crossref
Anna I. Kakafika, Dimitri P. Mikhailidis, Asterios Karagiannis & Vasilios G. Athyros. (2007) The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome. The Journal of Clinical Pharmacology 47:5, pages 642-652.
Crossref
Vasilios G. Athyros, Emmanuel S. Ganotakis, Moses S. Elisaf, Evangelos N. Liberopoulos, Ioannis A. Goudevenos & Asterios Karagiannis. (2007) Prevalence of vascular disease in metabolic syndrome using three proposed definitions. International Journal of Cardiology 117:2, pages 204-210.
Crossref
T. D. Filippatosm, C. S. Derdemezis, D. N. Kiortsis, A. D. Tselepis & M. S. Elisaf. (2014) Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. Journal of Endocrinological Investigation 30:4, pages 323-326.
Crossref
K.A.L. Darvall, R.C. Sam, S.H. Silverman, A.W. Bradbury & D.J. Adam. (2007) Obesity and Thrombosis. European Journal of Vascular and Endovascular Surgery 33:2, pages 223-233.
Crossref
Jordi Salas-Salvadó, Miguel A. Rubio, Montserrat Barbany & Basilio Moreno. (2007) Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Medicina Clínica 128:5, pages 184-196.
Crossref
Irene Gazi, Vasilis Tsimihodimos, Theodosios D Filippatos, Vasilios G Saougos, Eleni T Bairaktari, Alexandros D Tselepis & Moses Elisaf. (2006) LDL cholesterol estimation in patients with the metabolic syndrome. Lipids in Health and Disease 5:1.
Crossref
Sofia G. Tsouli, Evangelos N. Liberopoulos, Dimitri P. Mikhailidis, Vasilios G. Athyros & Moses S. Elisaf. (2006) Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 55:10, pages 1293-1301.
Crossref
Michael Blaha & Tom A. Elasy. (2006) Clinical Use of the Metabolic Syndrome: Why the Confusion?. Clinical Diabetes 24:3, pages 125-131.
Crossref
Paula Xavier Picon, Claudete Maria Zanatta, Fernando Gerchman, Themis Zelmanovitz, Jorge Luiz Gross & Luís Henrique Canani. (2006) Análise dos critérios de definição da síndrome metabólica em pacientes com diabetes melito tipo 2. Arquivos Brasileiros de Endocrinologia & Metabologia 50:2, pages 264-270.
Crossref
Lynn E. Eberly, Ronald Prineas, Jerome D. Cohen, Gabriela Vazquez, Xin Zhi, James D. Neaton & Lewis H. Kuller. (2006) Metabolic Syndrome. Diabetes Care 29:1, pages 123-130.
Crossref
E. J. DiamantopoulosV. G. Athyros, G. K. Yfanti, E. N. Migdalis, M. Elisaf, P. E. Vardas, A. S. Manolis, D. T. Karamitsos, E. S. Ganotakis & D. Hatseras. (2016) The contrOL of dYslipideMia in outPatIent clinics in GreeCe (Olympic) Study. Angiology 56:6, pages 731-741.
Crossref
E. N. Liberopoulos, D. P. Mikhailidis & M. S. Elisaf. (2005) Diagnosis and management of the metabolic syndrome in obesity. Obesity Reviews 6:4, pages 283-296.
Crossref
Nicolas W. Shammas & Eric J. Dippel. (2005) Evidence-based management of peripheral vascular disease. Current Atherosclerosis Reports 7:5, pages 358-363.
Crossref
Vasilios G. Athyros, Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, Triandafillos P. Didangelos, Athanasia Peletidou, Drosia Kleta, Asterios Karagiannis, Anna I. Kakafika, Konstantinos Tziomalos & Moses Elisaf. (2005) Targeting vascular risk in patients with metabolic syndrome but without diabetes. Metabolism 54:8, pages 1065-1074.
Crossref
Haralampos J. MilionisEvangelos RizosJohn GoudevenosKonstantinos SeferiadisDimitri P. MikhailidisMoses S. Elisaf. (2005) Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects. Stroke 36:7, pages 1372-1376.
Crossref
Anthony S Wierzbicki. (2016) The role of dyslipidaemia in coronary heart disease. The British Journal of Diabetes & Vascular Disease 5:1_suppl, pages S2-S6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.